Corcept Therapeutics Cash from Investing (TTM) Analysis

Corcept Therapeutics Inc (CORT)

23.00 +0.70 (+3.14%) USD | NASDAQ | Apr 23, 16:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2003. Upgrade now.

Date	Value
December 31, 2023	90.91M
September 30, 2023	56.57M
June 30, 2023	161.35M
March 31, 2023	143.64M
December 31, 2022	-114.33M
September 30, 2022	43.38M
June 30, 2022	22.37M
March 31, 2022	88.91M
December 31, 2021	136.13M
September 30, 2021	6.875M
June 30, 2021	-31.60M
March 31, 2021	-142.28M
December 31, 2020	-119.26M
September 30, 2020	-192.47M
June 30, 2020	-182.52M
March 31, 2020	-97.73M
December 31, 2019	-117.83M
September 30, 2019	-57.60M
June 30, 2019	-36.79M
March 31, 2019	-56.84M
December 31, 2018	-90.77M
September 30, 2018	-116.46M
June 30, 2018	-94.60M
March 31, 2018	-88.34M
December 31, 2017	-73.46M

Date	Value
September 30, 2017	-46.08M
June 30, 2017	-34.53M
March 31, 2017	-19.58M
December 31, 2016	-0.194M
September 30, 2016	-0.102M
June 30, 2016	-0.012M
March 31, 2016	-0.005M
December 31, 2015	-0.017M
September 30, 2015	-0.034M
June 30, 2015	-0.05M
March 31, 2015	-0.098M
December 31, 2014	-0.174M
September 30, 2014	-0.214M
June 30, 2014	-0.263M
March 31, 2014	-0.219M
December 31, 2013	-0.127M
September 30, 2013	-0.145M
June 30, 2013	-0.132M
March 31, 2013	-0.162M
December 31, 2012	-0.151M
September 30, 2012	-0.118M
June 30, 2012	-0.066M
March 31, 2012	-0.032M
December 31, 2011	-0.025M
September 30, 2011	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-192.47M

Minimum

Sep 2020

161.35M

Maximum

Jun 2023

-18.01M

Average

-31.60M

Median

Jun 2021

Cash from Investing (TTM) Benchmarks